SCHEMBL3759237

SCHEMBL3759237

CC1(C)CC(=O)c2sc(N3CCOCC3)c(-c3ccnc(-c4cccc(C(=O)NCC5CCN(C(=O)O)CC5)c4)c3)c2C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 3/20 0.38
HDAC1 Q13547 3/20 0.38
LMNA P02545 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
ACACB O00763 1/20 0.37
ACACA Q13085 1/20 0.37
MAPK13 O15264 1/20 0.37
HSPB1 P04792 1/20 0.37
MAPK12 P53778 1/20 0.37
MAPK11 Q15759 1/20 0.37
MAPK14 Q16539 1/20 0.37
JAK2 O60674 1/20 0.37
MAP4K4 O95819 1/20 0.36
ROCK2 O75116 4/20 0.34
NAPEPLD Q6IQ20 2/20 0.34
ROCK1 Q13464 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3751656 0.91 PIM1 (0.40) KDM1AHDAC1LMNASMN1; SMN2ALDH1A1
SCHEMBL3758952 0.87 CYP2C19 (0.38) KDM1AHDAC1ALDH1A1POLBMAPK14
SCHEMBL3765032 0.86 MAPK14 (0.36) KDM1AHDAC1ALDH1A1POLBMAPK14
SCHEMBL3762510 0.86 PRKD1 (0.41) KDM1AHDAC1JAK2MAP4K4
SCHEMBL3764901 0.85 PIK3CA (0.41) KDM1AHDAC1JAK2SCN9ABUB1
SCHEMBL3762759 0.84 PRKDC (0.40) KDM1AHDAC1LMNAALDH1A1POLB
SCHEMBL3754939 0.84 KDM1A (0.39) KDM1AHDAC1ALDH1A1JAK2BUB1
SCHEMBL3760088 0.84 KDM1A (0.40) KDM1AHDAC1POLBJAK2ROCK2
SCHEMBL3756615 0.84 ATR (0.38) KDM1AHDAC1POLBMAPK14JAK2
SCHEMBL3761348 0.83 BUB1 (0.37) ALDH1A1JAK2BUB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA KDM1A 3543/4885HDAC1 669/4885LMNA 4870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.